Advanced search
Publication Cover
Expert Review of Gastroenterology & Hepatology Volume 13, 2019 - Issue 4
Submit an article Journal homepage
3,891
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis

Judy W. NeeDivision of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAView further author information
,
Jeffrey M. JohnstonIronwood Pharmaceuticals, Inc., Cambridge, MA, USAView further author information
,
Elizabeth P. SheaIronwood Pharmaceuticals, Inc., Cambridge, MA, USACorrespondence[email protected]
View further author information
,
Courtney E. WallsIronwood Pharmaceuticals, Inc., Cambridge, MA, USAView further author information
,
Kenneth TrippIronwood Pharmaceuticals, Inc., Cambridge, MA, USAView further author information
,
Steven ShiffAllergan plc, Madison, NJ, USAView further author information
,
Susan M. FoxAllergan plc, Madison, NJ, USAView further author information
,
Wieslaw BochenekAllergan plc, Madison, NJ, USAView further author information
,
Darren WeissmanAllergan plc, Madison, NJ, USAView further author information
,
Mark G. CurrieIronwood Pharmaceuticals, Inc., Cambridge, MA, USAView further author information
&
Anthony J. LemboDivision of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAView further author information
 show all
Pages 397-406 | Received 20 Nov 2018, Accepted 21 Jan 2019, Published online: 18 Feb 2019

Related Research Data

Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis
Source: Figshare
Irritable bowel syndrome and ischemic colitis: evidence supporting the increased use of alosetron
Source: SAGE Publications
A Novel Role of Cyclic GMP in Colonic Sensory Neurotransmission in Healthy and TNBS-Treated Mice
Source: Elsevier BV
Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety
Source: Ovid Technologies (Wolters Kluwer Health)
Diseases and Drugs That Increase Risk of Acute Large Bowel Ischemia
Source: Elsevier BV
The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking, and Disease Burden
Source: Ovid Technologies (Wolters Kluwer Health)
American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation
Source: Ovid Technologies (Wolters Kluwer Health)
Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis
Source: Figshare
Pilot Study on the Effect of Linaclotide in Patients With Chronic Constipation
Source: Ovid Technologies (Wolters Kluwer Health)
Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation
Source: Elsevier BV

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.